MAR 11, 2021 8:00 AM PST

Bye-Bye Burning: A New UTI Vaccine

WRITTEN BY: Tara Fernandez

Researchers have developed a vaccine that “trains” the bladder to fight back against the bacteria that cause urinary tract infections or UTIs. The vaccine is administered directly into the bladder, boosting the weak immune response against bacteria in the urinary tract, which is thought to be a significant contributing factor to UTIs.

UTIs are the most common outpatient infections in the U.S., with as many as 50 percent of women experiencing this painful and disruptive condition in their lifetimes.

According to immunology expert and study lead Soman Abraham, reprogramming the immune system using vaccines can help the body stave off UTI-causing bacteria such as E. coli. The problem is that while this approach shows promise, it has fallen flat in clinical trials, with other vaccines in development demonstrating very little success in keeping UTIs at bay in patients.

“There are currently no effective UTI vaccines available for use in the US in spite of the high prevalence of bladder infections,” Abraham said. “Our study describes the potential for a highly effective bladder vaccine that can not only eradicate residual bladder bacteria, but also prevent future infections.”

Abraham and colleagues tested their new system in a mouse model of UTI, in which they observed that before treatment, very few immune cells were activated to eliminate pathogenic bacteria. This immune phenomenon resulted in the frequent resurgence of infections.

Jianxuan Wu, another investigator for the lab, said: “The new vaccine strategy attempts to ‘teach’ the bladder to more effectively fight off the attacking bacteria.”

“By administering the vaccine directly into the bladder where the residual bacteria harbor, the highly effective vaccine antigen, in combination with an adjuvant known to boost the recruitment of bacterial clearing cells, performed better than traditional intramuscular vaccination.”

These are encouraging findings, said Abraham, who is optimistic about taking the treatment to clinical trials. Indeed, if it proves effective in humans, clinical adoption for the new therapy appears to be a relatively straightforward process, particularly as the individual components of the new vaccine have already been cleared as safe to use by regulatory bodies.

 


Sources: Duke University, PNAS.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
DEC 27, 2020
Microbiology
A Potential Treatment Approach for Crohn's Disease
DEC 27, 2020
A Potential Treatment Approach for Crohn's Disease
Researchers may have found a way to treat or prevent Crohn's disease, one of the most common forms of inflammatory bowel ...
FEB 03, 2021
Immunology
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
FEB 03, 2021
Severely Ill COVID-19 Patients may have Longer Immunity Against the Virus
Researchers are still studying how long a person can stay immune against COVID-19 following infection. A new study by a ...
APR 08, 2021
Immunology
It's Not Just Cholesterol That Clogs Arteries
APR 08, 2021
It's Not Just Cholesterol That Clogs Arteries
Researchers have discovered a gene that is directly linked to the development of cardiovascular diseases, such as high b ...
APR 08, 2021
Immunology
What's That Frozen Pizza Doing to Your Immune System?
APR 08, 2021
What's That Frozen Pizza Doing to Your Immune System?
In a recent study, scientists found that commonly-used chemical additives added to processed foods can have toxic effect ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 11, 2021
Genetics & Genomics
Trial Shows Personalized Cancer Vaccines are Safe
APR 11, 2021
Trial Shows Personalized Cancer Vaccines are Safe
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...
Loading Comments...